These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25452846)

  • 41. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences.
    Barbara G; Cremon C; Stanghellini V
    Curr Opin Gastroenterol; 2014 Jul; 30(4):352-8. PubMed ID: 24811054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease.
    Kovács Z; Kovács F
    Int J Psychiatry Med; 2007; 37(3):245-55. PubMed ID: 18314852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "I know this is bad for me, but...": a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease: part II.
    Fletcher PC; Jamieson AE; Schneider MA; Harry RJ
    Clin Nurse Spec; 2008; 22(4):184-91. PubMed ID: 18596487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An initial report of sleep disturbance in inactive inflammatory bowel disease.
    Keefer L; Stepanski EJ; Ranjbaran Z; Benson LM; Keshavarzian A
    J Clin Sleep Med; 2006 Oct; 2(4):409-16. PubMed ID: 17557469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between early childhood otitis media and pediatric inflammatory bowel disease: an exploratory population-based analysis.
    Shaw SY; Blanchard JF; Bernstein CN
    J Pediatr; 2013 Mar; 162(3):510-4. PubMed ID: 23084703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of Ischaemic Heart Disease in Patients with Inflammatory Bowel Disease: Cohort Study Using the General Practice Research Database.
    Close H; Mason JM; Wilson DW; Hungin AP; Jones R; Rubin G
    PLoS One; 2015; 10(10):e0139745. PubMed ID: 26461954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome--women are more seriously affected than men.
    Faresjö A; Grodzinsky E; Johansson S; Wallander MA; Timpka T; Akerlind I
    Am J Gastroenterol; 2007 Feb; 102(2):371-9. PubMed ID: 17156145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control study.
    Hervé S; Beaugerie L; Bouhnik Y; Savoye G; Colombel JF; Dyard F; Hourmand-Ollivier I; Dao T; Vial M; Lerebours E
    Neurogastroenterol Motil; 2009 Nov; 21(11):1170-e102. PubMed ID: 19460104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.
    Penny KI; Smith GD; Ramsay D; Steinke DT; Kinnear M; Penman ID
    Int J Nurs Stud; 2008 Dec; 45(12):1715-20. PubMed ID: 18829027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA; Covington PS; Patrick DL
    Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
    Lee YT; Hu LY; Shen CC; Huang MW; Tsai SJ; Yang AC; Hu CK; Perng CL; Huang YS; Hung JH
    PLoS One; 2015; 10(7):e0133283. PubMed ID: 26222511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Irritable bowel syndrome: a co-twin control analysis.
    Wojczynski MK; North KE; Pedersen NL; Sullivan PF
    Am J Gastroenterol; 2007 Oct; 102(10):2220-9. PubMed ID: 17897337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022.
    Grasa L; Brzozowski T; Seelaender M
    Front Pharmacol; 2022; 13():1055030. PubMed ID: 36339615
    [No Abstract]   [Full Text] [Related]  

  • 56. What calprotectin cut-offs should apply for IBD in general practice?
    Landis D; Hungin P; Hommes D
    Frontline Gastroenterol; 2016 Apr; 7(2):151-152. PubMed ID: 27103985
    [No Abstract]   [Full Text] [Related]  

  • 57. Occult inflammation causes IBS symptoms in patients with IBD.
    Wood NJ
    Nat Rev Gastroenterol Hepatol; 2010 Jun; 7(6):302. PubMed ID: 20540181
    [No Abstract]   [Full Text] [Related]  

  • 58. Randomised controlled trial of mesalazine in IBS.
    Barbara G; Cremon C; Annese V; Basilisco G; Bazzoli F; Bellini M; Benedetti A; Benini L; Bossa F; Buldrini P; Cicala M; Cuomo R; Germanà B; Molteni P; Neri M; Rodi M; Saggioro A; Scribano ML; Vecchi M; Zoli G; Corinaldesi R; Stanghellini V
    Gut; 2016 Jan; 65(1):82-90. PubMed ID: 25533646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
    Pineton de Chambrun G; Neut C; Chau A; Cazaubiel M; Pelerin F; Justen P; Desreumaux P
    Dig Liver Dis; 2015 Feb; 47(2):119-24. PubMed ID: 25488056
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.